Milestone Scientific Inc.
$0.29
▼
-4.86%
2026-04-21 08:11:00
www.milestonescientific.com
ASE: MLSS
Explore Milestone Scientific Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$23.33 M
Current Price
$0.29
52W High / Low
$1.11 / $0.22
Stock P/E
—
Book Value
$0.04
Dividend Yield
—
ROCE
-155%
ROE
-1.32%
Face Value
—
EPS
$-0.07
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15
Beta
0.85
Debt / Equity
36.27
Current Ratio
1.81
Quick Ratio
0.89
Forward P/E
-6.88
Price / Sales
2.47
Enterprise Value
$22.04 M
EV / EBITDA
-3.92
EV / Revenue
2.46
Rating
Strong Buy
Target Price
$1
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Zentek Ltd. | $0.5 | — | $73.33 M | — | -64.39% | -56.64% | $2.5 / $0.63 | $0.08 |
| 2. | AngioDynamics, Inc. | $10.79 | — | $449.55 M | — | -11.8% | -17.47% | $13.99 / $8.36 | $4.16 |
| 3. | Microbot Medical Inc. | $2.3 | — | $154.46 M | — | -18.87% | -32.42% | $4.67 / $1.6 | $1.16 |
| 4. | GlucoTrack, Inc. | $0.78 | — | $1.55 M | — | -524.96% | 381.2% | $15.9 / $0.62 | $3.06 |
| 5. | Nephros, Inc. | $3.07 | 27.37 | $32.68 M | — | 10.54% | 12.71% | $6.42 / $1.64 | $0.96 |
| 6. | Precision Optics Corporation, Inc. | $4.44 | — | $47.43 M | — | -40.7% | -73.56% | $6.04 / $3.55 | $1.21 |
| 7. | Stevanato Group S.p.A. | $15.86 | 26.32 | $4.33 B | 0.39% | 9.9% | 9.67% | $28 / $12.89 | $6.28 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2.06 M | 2.36 M | 2.32 M | 2.23 M | 2.01 M | — |
| Operating Profit | -1.08 M | -1.13 M | -1.48 M | -2 M | -2.04 M | — |
| Net Profit | -1.09 M | -1.15 M | -1.48 M | -1.99 M | -2.04 M | — |
| EPS in Rs | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 8.97 M | 8.63 M | 9.83 M | 8.81 M |
| Operating Profit | -5.7 M | -6.76 M | -7.11 M | -8.83 M |
| Net Profit | -5.72 M | -4.71 M | -6.93 M | -8.71 M |
| EPS in Rs | -0.07 | -0.06 | -0.09 | -0.11 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 7.81 M | 9.8 M | 11.37 M | 13.7 M |
| Total Liabilities | 4.99 M | 3.96 M | 3.36 M | 3.7 M |
| Equity | 2.81 M | 5.83 M | 8.01 M | 10.23 M |
| Current Assets | 7.48 M | 9.29 M | 10.79 M | 12.97 M |
| Current Liabilities | 4.13 M | 3.74 M | 3.08 M | 3.3 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -2.92 M | -2.92 M | -5.33 M | -6.03 M |
| Investing CF | -0.02 M | 2.97 M | -2.97 M | -0.01 M |
| Financing CF | 0.79 M | 0.23 M | 2.56 M | -0.01 M |
| Free CF | -2.93 M | -2.93 M | -5.33 M | -6.04 M |
| Capex | -0.02 M | -0.01 M | -0 M | -0.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -12.19% | 11.6% | — | — |
| Earnings Growth % | 31.97% | 20.41% | — | — |
| Profit Margin % | -54.62% | -70.51% | -98.87% | — |
| Operating Margin % | -78.3% | -72.31% | -100.24% | — |
| Gross Margin % | 74.56% | 69.12% | 55.65% | — |
| EBITDA Margin % | -76.73% | -70.78% | -98.61% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.